leukemia News
Most Popular leukemia Story
EntreMed lands $10M deal to fund cancer drug trials
EntreMed ($ENMD) has struck a deal to bring in much-needed capital to support development of its experimental kinase inhibitor for attacking multiple types of cancer. And the Rockville, MD-based drug Read more...
Latest Headlines
- January 23, 2012
- August 26, 2011
- August 11, 2011
- January 31, 2011
- December 6, 2010
- September 10, 2009
- June 17, 2009
- May 16, 2008
- April 2, 2008
- March 19, 2008
- January 28, 2008
- January 22, 2008
- January 14, 2008
- January 8, 2008
- January 3, 2008
- December 18, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
